Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model

por Kurma, Keerthi, Zeybek Kuyucu, Ayca, Roth, Gaël S., Sturm, Nathalie, Mercey-Ressejac, Marion, Abbadessa, Giovanni, Yu, Yi, Lerat, Herve, Marche, Patrice N., Decaens, Thomas, Macek Jilkova, Zuzana
Publicado 2022